Changes in cellular components of spleen and lymph node cells and the effector cells responsible for Meth A tumor eradication induced by zinostatin stimalamer

Cancer Research

Volumn 56, Issue 8, 1996, Pages 1868-1873

  Masuda, Etsuko ^a   Maeda, Hiroshi ^b  

^a ASTELLAS PHARMA INC   (Japan)

^b KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ZINOSTATIN MALEIC ACID STYRENE COPOLYMER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; EFFECTOR CELL; FEMALE; FLOW CYTOMETRY; HOST RESISTANCE; LYMPH NODE CELL; MACROPHAGE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE; TUMOR REGRESSION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, LY; ANTIGENS, THY-1; B-LYMPHOCYTES; FEMALE; FIBROSARCOMA; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LYMPH NODES; LYMPHOCYTE DEPLETION; MACROPHAGES; MALEIC ANHYDRIDES; MICE; MICE, INBRED BALB C; POLYSTYRENES; SPLEEN; T-LYMPHOCYTES; TIME FACTORS; ZINOSTATIN;

EID: 0029932685     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Masuda, E , and Maeda, H. Antitumor resistance induced by zinostatin stimalamer (ZSS), a polymer-conjugated neocarzinostatin (NCS) derivative. I. Meth A tumor eradication and tumor-neutralizing activity in mice pretreated with ZSS or NCS. Cancer Immunol. Immunother., 40, 329-338, 1995.
2. Maeda, H., Takeshita, J., and Kanamaru, R. A lipophilic derivative of neocarzinostatin. A polymer conjugation of an antitumor protein antibiotic Int. J Pept. Protein Res., 14: 81-87, 1979
3. Maeda, H., Ueda, M., Morinaga, T., and Matsumoto, T. Conjugation of poly(styrene-co-maleic acid) derivatives to the antitumor protein neocarzinostatin, pronounced improvements in pharmacological properties. J. Med. Chem., 28. 455-461, 1985.
4. Numasaki, Y , Takahashi, K , Masuda, E., Nohara, C , and Maeda, H. Antitumor effects of a new antitumor agent, zinostatin stimalamer (YM881): effects on experimental tumors in vitro and in vivo Jpn J Cancer Chemother., 18: 2289-2294, 1991
5. Winn, H. Immune mechanisms in homotransplantation. II Quantitative assay of the immunologic activity of lymphoid cells stimulated by tumor homografts. J. Immunol., 86. 228-239, 1961.
6. Dialynas, D. P., Quan, Z. S., Wall, K A , Pierres, A., Quintans, J., Loken, M. R., Pierres, M , and Fitch, F. W. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5 similarity of L3T4 to the human Leu-3/T4 molecule. J. Immunol., 131, 2445-2451, 1983.
7. Ledbetter, J. A., and Herzenberg, L A. Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol. Rev., 47: 63-90, 1979.
8. Ledbetter, J. A., Evans, R. L , Lipinski, M., Cunningham-Rundles, C., Good, R. A., and Herzenberg, L. A. Evolutionary conservation of surface molecules that distinguish T lymphocyte helper/inducer and T cytotoxic/suppressor subpopulations in mouse and man J Exp Med , 153 310-323, 1981.
9. Kasai, M., Iwamori, M., Nagai, Y., Okumura, K., and Tada, T A glycolipid on the surface of mouse natural killer cells Eur. J. Immunol., 10: 175-180, 1980.
10. Springer, T., Galfré, G., Secher, D. S., and Milstein, C. Mac-1, a macrophage differentiation antigen identified by monoclonal antibody. Eur. J. Immunol., 9: 301-306, 1979.
11. Masuda, E , Takemoto, T., Tatsuno, T., and Obara, T. Immunosuppressive effect of a trichothecene mycotoxin. Fusarenon-X in mice. Immunology, 45: 743-749, 1982.
12. Ault, K A., and Springer, T. A. Cross-reaction of a rat-anti-mouse phagocyte-specific monoclonal antibody (anti-Mac-1) with human monocytes and natural killer cells. J. Immunol., 126: 359-364, 1981.
13. Thomson, A W., and Fowler, E. F. Carrageenan: a review of its effects on the immune system. Agents Actions, 11: 265-273, 1981.
14. Geran, R. I., Greenberg, N. H., Macdonald, M. M., Schumacher, A. M., and Abbott, B. J. Protocols for screening chemical agents and natural products against animal tumors and other biological systems. Cancer Chemother Rep., 3: 47-52, 1972.
15. El-Sady, E., Parker, D , and Turk, J. L. The effect of cyclophosphamide in vivo on the expression of lymphocyte markers, detected by monoclonal antibodies, in the rat. Int J. Immunopharmacol., 8: 961-966, 1986.
16. Stockman, G. D , Heim, L R., South, M. A., and Trentin, J. J Differential effects of cyclophosphamide on the B and T cell compartments of adult mice. J. Immunol., 110: 277-282, 1973.
17. Hellstrom, K. E., and Hellstrom, I. Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens. Adv. Immunol , 18: 209-277, 1974
18. Heppner, G. H., and Calabresi, P. Suppression by cytosine arabinoside of serum-blocking factors of cell-mediated immunity to syngeneic transplants of mouse mammary tumors J. Natl Cancer Inst , 48: 1161-1167, 1972.
19. Steele, G., Sjogren, H O , and Ankerst, J. The effects of cyclophosphamide on in vitro correlates of tumor immunity. Int. J. Cancer, 14: 743-752, 1974.
20. Barbuto, J. A M , Grimes, W. J , and Hersh, E. M. Antibodies to tumor necrosis factor: a component of B cell immune responses with a role in tumor/host interaction. Cancer Immunol. Immunother., 40: 31-36, 1995.
21. Takeshita, J., Maeda, H , and Kanamaru, R In vitro mode of action, pharmacokinetics, and organ specificity of poly(maleic acid-styrene)-conjugated neocarzinostatin, SMANCS. Gann, 73: 278-284, 1982.
22. Akagawa, K , and Tokunaga, T Appearance of a cell surface antigen associated with the activation of peritoneal macrophages in mice. Microbiol Immunol., 26. 831-842, 1982
23. - cells and for IFN-α and IL-4. J. Immunol., 151, 3440-3449, 1993.
24. Mercurio, A. M . Schwarting, G. A., and Robbins, P. W. Glycolipids of the mouse peritoneal macrophage: alterations in amount and surface exposure of specific glycolipid species occur in response to inflammation and tumoricidal activation. J Exp. Med., 160: 1114-1125, 1984
25. Suttles, J., Schwarting, G. A., Hougland, M. W , and Stout, R D. Expression of asialo GM1 on a subset of adult murine thymocytes: histological localization and demonstration that the asialo GM1-positive subset contains both the functionally mature and the proliferating thymocyte subpopulations J Immunol , 138: 364-372, 1987
26. Stitz, L , Baenziger, J., Pircher, H., Hengartner, H , and Zinkernagel, R M. Effect of rabbit anti-asialo GM1 treatment in vivo or with anti-asialo GM1 plus complement in vitro on cytotoxic T cell activities. J. Immunol., 136: 4674-4680, 1986
27. M1 on the surface membrane of alloimmune cytotoxic T lymphocytes. J. Immunol , 136: 1586-1591, 1986.
28. Knobloch, C., and Dennert, G. Asialo-GM1-positive T killer cells are generated in F1 mice injected with parental spleen cells J Immunol , 140: 744-749, 1988
29. Harada, T., Kan, N, Ichinose, Y , Moriguchi, Y., Li, L , Sugie, T., Okino, T , and Imamura, M. The synergistic antitumor effect of recombinant interleukin-1 and low-dose of cyclophosphamide in tumor-bearing mice. J Surg. Oncol , 56. 39-45, 1994.
30. Tanaka, S , Numasaki Y , and Maeda, H. Action mechanisms of zinostatin stimalamer (YM881) Jpn. J. Cancer Chemother., 18: 2295-2300, 1991